Immuron posts CEO presentation for TechKnow Invest Roadshow

PUBT · 2d ago
Immuron posts CEO presentation for TechKnow Invest Roadshow
  • Immuron published a CEO presentation for the TechKnow Invest Roadshow held today at Sofitel Melbourne on Collins.
  • Presentation highlights Travelan (IMM-124E), an oral hyperimmune bovine antibody product positioned to reduce travelers’ diarrhea risk; sold as a dietary supplement in the U.S.
  • Slides also cover IMM-529 for recurrent C. difficile, citing preclinical results showing 80% primary prevention, 67% recurrence protection, 78.6% treatment.
  • Materials include ProIBS distribution in Australia and New Zealand, positioned for IBS symptom relief as a certified medical device.
  • Release links: https://www.immuron.com.au/ | https://www.travelan.com


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Immuron Limited published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-081582), on July 27, 2026, and is solely responsible for the information contained therein.